Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
140
天
Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in France
作者
JeanSebastien Frenel; Alexandre de Nonnevile; Catherine Guerin-Charbonnel; Jean Zeghondy; Laurent Mathiot; Audrey Mailliez; François Poumeaud; Nicolas Isambert; Monica Arnedos; Fanny Le Du; Loick Galland; Rayan Kabirian; Severine Guiu; Laura Poestch; Elise Deluche; François Cherifi; Florence Dalenc; Elsa Volant; Barbara Pistilli; Tevy San; Thomas Bachelot; Anne Patsouris; François Bocquet; Caroline Bailleux; Delphine Loirat; Louis Larrouquere展开收起
作者单位
Medical Oncology, Institut de Cancérologie de l’Ouest, Saint-Herblain, France; Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France; Oncology Data Factory And Analytics, Institut de Cancérologie de l’Ouest, Saint-Herblain, France; Medical Oncology, Gustave Roussy, Villejuif, France; Medical Oncology, Centre Oscar Lambret, Lille, France; Medical Oncology, Oncopole, IUCT, Claudius Regaud, Toulouse, France; Medical Oncology, CHU Poitiers, Poitiers, France; Medical Oncology, Centre Bergonié, Bordeaux, France; Medical Oncology, Centre Eugène Marquis, Rennes, France; Medical Oncology, Centre Georges-François Leclerc, Saint-Herblain, France; Medical Oncology, Institut Curie, Paris, France; Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France; Medical Oncology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France; Medical Oncology, CHU de Limoges, Limoges, France; Medical Oncology, Centre François Baclesse, Caen, France; Medical Oncology, CORT 37, Chambray-lès-Tours, France; Medical Oncology, Centre Léon Bérard, Lyon, France; Medical Oncology, Institut de Cancérologie de l’Ouest, Angers, France; Data Factory and Analytics, Institut de Cancérologie de l’Ouest, Saint-Herblain, France; Medical Oncology, Centre Antoine Lacassagne, Nice, France展开收起
145
天
Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons
作者
Jingjing Xiao; Meiling Huang; Changjiao Yan; Zhe Wang; Ting Wang展开收起
作者单位
Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China展开收起
282
天
Performance of large language models in ambiguous treatment scenarios of early breast cancer
作者
Anton Oseledchyk; Walter Paul Weber; Benjamin Kasenda展开收起
作者单位
Medical Oncology, University Hospital Basel, Basel, Switzerland; Breast Cancer Center, University Hospital Basel, Basel, Switzerland展开收起
74
天
Transcriptomic signatures of mind-body transformations therapy in breast cancer: Downregulation of the interferon signaling pathway
作者
Stefania Cocco; Mauro Cozzolino; Michela Piezzo; Giovanna Celia; Daniela Barberio; Valentina Abate; Alessandra Calabrese; Claudia Von Arx; Rossana Di Rienzo; Susan Costantini; Alfredo Budillon; Michelino De Laurentiis展开收起
作者单位
Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy; Department of Human, Philosophical and Educational Sciences, University of Salerno, Salerno, Italy; Department of Theoretical and Applied Sciences, Ecampus University, Novedrate, Italy; Departmental Simple Unit of Psycho-oncology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy; Experimental Pharmacology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy; Scientific Directorate, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy展开收起
133
天
Cost-effectiveness of abbreviated breast MRI and contrast-enhanced mammography for women with extremely dense breasts in a national breast cancer screening program: a micro-simulation study
作者
Mengmeng Li; Marcel J.W. Greuter; Keris Poelhekken; Monique D. Dorrius; Karin M. Vermeulen; Antoinette D.I. van Asselt; Geertruida H. de Bock展开收起
作者单位
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Health Science, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands展开收起
123
天
Revisiting HER2-negative breast cancer in the era of HER2-low and HER2-ultralow expression: Assessment of interobserver variability
作者
Xiao Huang; Sarah Anderson; Valeria Dal Zotto; Shuko Harada; Andrea G Kahn; Meiling Zhou; Kui Zhang; Kanako Okamoto; Shi Wei展开收起
作者单位
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA; Department of Mathematical Sciences, Michigan Technological University, Houghton, MI, USA; Department of Statistics, Grand Valley State University, Allendale, MI, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA展开收起
FAQ
BREAST审稿要多久?
截至2026-11-19,CrushSCI 收录了 BREAST 的 14 篇完整审稿记录。最快一篇从收稿到录用用了 55 天(End-of-life care values and treatment preferences among Japanese breast cancer patients and families: A dyadic cross-sectional study,2026-06-16 收稿,2026-08-10 录用),最慢一篇用了 307 天;平均 144.1 天,中位数 136.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
